LONG TERM USE OF CAPECITABINE IN PATIENTS WITH LOCALLY RECURRENT OR METASTATIC BREAST CANCER

被引：0
|
作者：
Josephs, D. H. [1 ]
Mir, R.
Siow, T. [1 ]
Dumas, L. E. [1 ]
Michalarea, V. [1 ]
Sawyer, E.
Mansi, J. L. [1 ]
机构：
[1] Guys & St Thomass NHS Trust, Guys Hosp, Med Oncol Off, London, England
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：139 / 140
页数：2
相关论文
共 50 条
  • [41] Capecitabine maintenance therapy after docetaxel/capecitabine combination chemotherapy in patients with metastatic breast cancer
    Gursoy, Pinar
    Surmeli, Zeki Gokhan
    Cakar, Burcu
    Arslan, Cagatay
    Zengel, Baha
    Karaca, Burcak
    Sezgin, Canfeza
    Karabulut, Bulent
    Sanli, Ulus Ali
    Uslu, Ruchan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [42] INCIDENCE OF GASTROINTESTINAL TOXICITY WITH CAPECITABINE MONOTHERAPY IN METASTATIC BREAST AND METASTATIC COLORECTAL CANCER PATIENTS
    Curry, Gemma
    Pranavan, Ganesalingam
    Yip, Desmond
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 116 - 116
  • [43] Phase II study decetaxel and capecitabine in patients with metastatic or recurrent gastric cancer
    Kim, Jong Gwang
    Sohn, Sang Kyun
    Kim, Dong Hwan
    Baek, Jin Ho
    Yu, Wansik
    Kim, Tae Bong
    Do, Young Rok
    Yea, Ji Won
    Shin, Dong Gun
    Lee, Jung Lim
    ANNALS OF ONCOLOGY, 2004, 15 : 234 - 234
  • [44] Dosage of capecitabine and cyclophosphamide combination therapy in patients with metastatic breast cancer
    Ohno, Shinji
    Mitsuyama, Shoshu
    Tamura, Kazuo
    Nishimura, Reiki
    Tanaka, Maki
    Hamada, Yuzo
    Kuroki, Shoji
    ANTICANCER RESEARCH, 2007, 27 (02) : 1009 - 1013
  • [45] Systematic review of the clinical effectiveness and costeffectiveness of capecitabine (Xeloda®) for locally advanced and/or metastatic breast cancer
    Jones, L
    Hawkins, N
    Westwood, M
    Wright, K
    Richardson, G
    Riemsma, R
    HEALTH TECHNOLOGY ASSESSMENT, 2004, 8 (05) : 1 - +
  • [46] Metastatic patterns in locally advanced and recurrent breast cancer: Is there any correlation with molecular subtype of breast cancer?
    Bansal, G. Jyoti
    Pinto, Kevin
    Davies, Eleri
    BREAST CANCER RESEARCH, 2017, 19
  • [47] Capecitabine monotherapy in pre-treated patients with metastatic breast cancer
    Gennatas, Constantine
    Michalaki, Vasiliki
    Psychogios, John
    Kairi-Vasilatou, E.
    Karvouni, Helen
    Kondi-Paphiti, Agathi
    ANNALS OF ONCOLOGY, 2006, 17 : 86 - 86
  • [48] Phase II study of docetaxel and capecitabine in patients with metastatic or recurrent gastric cancer
    Kim, JG
    Sohn, SK
    Kim, DH
    Baek, JH
    Sung, WJ
    Park, JY
    Kim, TB
    Jung, HY
    Yu, WS
    Lee, KB
    ONCOLOGY, 2005, 68 (2-3) : 190 - 195
  • [49] Effect of capecitabine on mean corpuscular volume in patients with metastatic breast cancer
    Karvellas, CJ
    Sawyer, M
    Hamilton, M
    Mackey, JR
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (04): : 364 - 368
  • [50] BITHERAPY WITH CAPECITABINE (CAPE) AND VINORELBINE (NBV) FOR PATIENTS WITH METASTATIC BREAST CANCER
    Bensalem, A.
    Bouzid, K.
    ANNALS OF ONCOLOGY, 2011, 22 : 64 - 64
12345